Market capitalization | $39.61b |
Enterprise Value | $41.67b |
P/E (TTM) P/E ratio | 31.16 |
EV/FCF (TTM) EV/FCF | 30.35 |
EV/Sales (TTM) EV/Sales | 6.40 |
P/S ratio (TTM) P/S ratio | 6.09 |
P/B ratio (TTM) P/B ratio | 6.67 |
Dividend yield | 0.68% |
Last dividend (FY24) | $0.94 |
As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.
21 Analysts have issued a Agilent Technologies forecast:
21 Analysts have issued a Agilent Technologies forecast:
Oct '24 |
+/-
%
|
||
Revenue | 6,510 6,510 |
5%
5%
|
|
Gross Profit | 3,766 3,766 |
1%
1%
|
|
EBITDA | 1,833 1,833 |
4%
4%
|
EBIT (Operating Income) EBIT | 1,576 1,576 |
4%
4%
|
Net Profit | 1,289 1,289 |
4%
4%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Head office | United States |
CEO | Padraig Mcdonnell |
Founded | 1999 |
Website | www.agilent.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.